Up to now, more than 1,400 shares have disclosed their 2023 annual reports. Of these, 391 shares recorded a record high of non-net profit deducted in 2023 (excluding individual stocks listed since 2023 and individual shares on the Beijing Stock Exchange); after excluding individual stocks with non-net profit of less than 50 million yuan in 2022 (avoiding the impact of the base effect), 33 shares doubled their non-net profit in 2023. Among the A-share listed companies that have disclosed their annual reports, there are only 9 individual stocks with a non-net profit growth rate of more than 20% for 5 consecutive years from 2019 to 2023. With the exception of Wanze shares and Soft Control shares, the remaining 7 shares with non-net profit deducted in 2023 all hit record highs since listing. Judging from the industry distribution, the 9 shares mentioned above are distributed among the 7 Shenwan second-tier industries. Among them, there are relatively many individual stocks belonging to the medical device and special equipment industry. In the medical device industry, two shares of Xinhua Healthcare and Pumen Technology have deducted non-net profit for 5 consecutive years from 2019 to 2023, and the growth rate of both exceeded 20%. (Data treasure)